IL21 and systemic lupus erythematosus: High serum levels of IL-21 were also detected in BXSB-Yaa mice (2), and blockade of the IL-21/IL-21R pathway slows the progression of lupus by decreasing lymphocyte activation and circulating IgG1 levels in BXSB-Yaa mice (86).